Features

Regulatory Focus Features are a RAPS member benefit. Please log in with your RAPS member account to view the full article content. Not a RAPS member? Join today.

Search:
 Search

8 May 2012

ClinicalTrials.gov: Requirements and Implementation Strategies

By Elaine Wong, MS, and Rebecca Williams, PharmD, MPH

The Food and Drug Administration Amendments Act of 2007 (FDAAA) established a requirement for certain clinical trials to be registered at trial initiation and to report summary results after trial completion in the public registry and results database called ClinicalTrials.gov.  This law is intended to facilitate enrollment in clinical trials, allow for tracking of the progress of such trials and address problems with the lack of timely dissemination of research findings. This article discusses key considerations, helpful hints and some lessons learned to help meet the requirements of FDAAA as well as the trial registration policy of the International Committee of Medical Journal Editors (ICMJE). [Read More...]